Films for reproducing digitally stored medical diagnostic images

• US 5,637,447 A
• Filed: 12/19/1995
• Issued: 06/10/1997
• Est. Priority Date: 12/19/1995
• Status: Expired due to Fees

• Current Assignee: CareStream Health Incorporated
• Original Assignee: Eastman Kodak Company
• Inventors: Dickerson, Robert E., Hershey, Stephen A., Beal, Richard E., Brayer, Franklin C., Jeffries, Patrick M.
• Primary Examiner(s): Huff, Mark F.
• Application Number:
  US08/574,508
• Time in Patent Office: 539 Days
• Field of Search: 430/966, 430/487, 430/567, 430/944
• US Class Current: 430/567
• CPC Class Codes: G03C 1/035 characterised by the crystal form or composition, e.g. mixed grain
• CPC Class Codes: G03C 1/295 Development accelerators
• CPC Class Codes: G03C 1/832 Methine or polymethine dyes
• CPC Class Codes: G03C 2200/58 Sensitometric characteristics
• CPC Class Codes: G03C 5/16 X-ray, infrared, or ultraviolet ray processes
• CPC Class Codes: G03C 5/164 Infrared processes
• CPC Class Codes: Y10S 430/145 Infrared
• CPC Class Codes: Y10S 430/167 X-ray

Abstract

A radiation-sensitive film for reproducing digitally stored medical diagnostic images through a series of laterally offset exposures by a controlled radiation source followed byprocessing in 90 seconds or less including development, fixing and drying is disclosed. The film exhibits an average contrast in the range of from 1.5 to 2.0, measured over a density above fog of from 0.25 to 2.0. An emulsion is provided in which silver bromochloride grains provided (a) containing at least 10 mole percent bromide, based on silver, (b) having a mean equivalent circular diameter of less than 0.40 μm, (c) exhibiting an average aspect ratio of less than 1.3, and (d) coated at a silver coverage of less than 40 mg/dm². Adsorbed to the surfaces of the silver bromochloride grains is at least one spectral sensitizing dye having an absorption half peak bandwidth in the spectral region of exposure by the controlled exposure source. The film also contains an infrared opacifying dye capable of reducing specular transmission through the film before, during and after processing to less than 50 percent, measured at a wavelength within the spectral region of from 850 to 1100 nm.

Claims

1. A radiation-sensitive silver halide film for reproducing digitally stored medical diagnostic images through a series of laterally offset exposures by a controlled radiation source followed by processing in 90 seconds or less, including development, fixing and drying, comprised of

a transparent film support and, coated on the support,

a hydrophilic colloid layer unit containing a silver halide emulsion,

wherein

(A) the film exhibits an average contrast in the range of from 1.5 to 2.0, measured over a density above fog of from 0.25 to 2.0,

(B) the emulsion layer

(1) contains silver bromochloride grains including grain faces lying in {100} crystal planes

(a) comprised of from 20 to 40 mole percent bromide, based on total silver,

(b) having a mean equivalent circular diameter of less than 0.40 μ

m,

(c) exhibiting an average aspect ratio of less than 1.3, and

(d) coated at a silver coverage of less than 40 mg/dm², and

(2) has adsorbed to the surfaces of the silver bromochloride grains at least one spectral sensitizing dye having an absorption half peak bandwidth in the spectral region of exposure by the controlled radiation source, and

(C) the film contains an infrared opacifying dye that is capable of reducing specular transmission through the film before, during and after processing to less than 50 percent, measured at a wavelength within the spectral region of from 850 to 1100 nm.

2. A film according to claim 1 wherein the silver bromochloride grains exhibit a coefficient of variation of grain size of less than 20 percent.

3. A film according to claim 1 wherein the silver bromochloride grains are coated at a coverage in the range of from 10 to 30 mg/dm², based on silver.

4. A film according to claim 1 wherein the silver bromochloride grains are cubic or tetradecahedral grains.

5. A film according to claim 1 wherein the infrared opacifying dye is coated in a processing solution permeable layer unit coated on a side of the support opposite the emulsion layer.

6. A film according to claim 1 wherein the infrared opacifying dye is a tricarbocyanine, tetracarbocyanine or pentacarbocyanine dye.

7. A film according to claim 1 wherein the opacifying dye satisfies the formula:

##STR5## where X₁ and X₂ each independently represent the atoms necessary to complete a nucleus that with (L--L)_p or (L═

L)_q form a 5 or 6-membered heterocyclic nucleus;

n, p and q each independently represents 0 or 1;

each L independently represents a methine group;

L₁ and L₂ are substituted methine groups that together form a 5- or 6-membered carbocyclic ring;

R₁ and R₂ each independently represents an alkyl, sulfoalkyl or carboxyalkyl group;

Y represents an amino or sulfonyl group;

the alkyl moleties contain in each instance from 1 to 6 carbon atoms; and

W is a counterion to balance the charge of the molecule.

8. A film according to claim 7 wherein the infrared opacifying dye is a 10,12-ethylene-11-[4-(N,N-dialkylthiocarbamoyl)-1-piperazino]thiatricarbocyanine.

9. A film according to claim 7 wherein the infrared opacifying dye is a 10,12-ethylene-11-(N,N-di-phenylamino)thiatricarbocyanine.

10. A film according to claim 1 wherein the film contains a hydrophilic colloid coating coverage on each side of the support of less than 45 mg/dm².

11. A film according to claim 1 wherein a colloid layer contains a thiaalkylene bis(ammonium salt).

12. A film according to claim 11 wherein the thiaalkylene bis(ammonium salt) is located in the hydrophilic colloid layer unit containing the silver halide emulsion.

13. A film according to claim 12 wherein the thiaalkylene bis(ammonium salt) is incorporated in a concentration of from 0.02 to 1.0 mg/dm².

14. A film according to claim 11 wherein the thiaalkylene his(ammonium salt) satisfies the formula:

space="preserve" listing-type="equation">Q.sup.1 --[(CH.sub.2).sub.n --S--].sub.m --(CH.sub.2).sub.p --Q.sup.2 X

where

m is an integer of from 1 to 3,

n and p are independently integers of from 1 to 6,

Q¹ and Q² are ammonio groups, and

X represents the ion or ions necessary to provide charge neutrality.

15. A film according to claim 1 wherein a developing agent is incorporated in a hydrophilic colloid layer of the film.

16. A film according to claim 15 wherein the concentration of the developing agent is limited to 1 equivalent, based on silver.

17. A film according to claim 15 wherein a hydroquinone developing agent is incorporated.

18. A film according to claim 17 wherein a supplemental developing agent is additionally incorporated chosen from the group consisting of p-aminophenols, p-phenylenediamines, reductones and 3-pyrazolidinones.

19. A film according to claim 15 wherein a combination of a hydroquinone developing agent, a 3-pyrazolidinone and a thiaalkylene bis(ammonium salt) are incorporated in the film.